Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

Subscribe To Our Latest Investor News

News Highlights
January 13, 2021
Virtual Bayer Pharma Media Day:

Bayer transforms pharma business through breakthrough innovation in healthcare

READ MORE
January 12, 2021

U.S. FDA grants Priority Review to New Drug Application for finerenone

READ MORE
January 7, 2021

Bayer issues new senior bonds with a volume of 4 billion euros

READ MORE
January 7, 2021

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

Read more
AD HOC

Discover Bayer’s Latest Ad Hoc Releases

READ MORE
Explore All
21 - 30of about 600 News
21 - 30of about 600 News
October 12, 2020
Not intended for U.S. and UK Media - American Society of Nephrology (ASN)’s Kidney Week 2020 Reimagined:
Finerenone Phase III FIDELIO-DKD study in chronic kidney disease and type 2 diabetes to be presented as late-breaking clinical trial at ASN 2020
READ MORE
September 30, 2020
Bayer to accelerate transformation to address challenging market environment and enable additional growth investments
READ MORE
September 28, 2020
Not intended for U.S. and UK Media
Bayer’s XtendFlex Soybeans Gain Final Key Regulatory Approval
READ MORE
September 17, 2020
ESMO Virtual Congress 2020:
New data reinforce strong clinical profile of Vitrakvi™ for patients of all ages with TRK Fusion Cancer including lung and thyroid tumors
READ MORE
September 15, 2020
Not intended for U.S. and UK Media
Bayer and Systems Oncology sign exclusive license agreement on innovative breast cancer treatment approach ERSO™
READ MORE
September 10, 2020
Bayer: Supervisory Board extends CEO Werner Baumann’s contract until the end of April 2024
READ MORE
September 09, 2020
Not intended for U.S. and UK Media
New England Journal of Medicine publishes final overall survival data for Nubeqa™ (darolutamide) showing treatment significantly extends life in men with non-metastatic prostate cancer
READ MORE
September 09, 2020
Bayer collaborates with Recursion to strengthen digital drug discovery and advance new therapies for fibrotic diseases
READ MORE
September 09, 2020
Not intended for U.S. and UK Media
Bayer completes acquisition of UK-based biotech company KaNDy Therapeutics Ltd.
READ MORE
September 08, 2020
Not intended for U.S. and UK Media
Bayer to showcase new data from evolving Oncology portfolio at ESMO Virtual Congress 2020
READ MORE
21 - 30of about 600 News
21 - 30of about 600 News